1 - 15 of 17 Results Clear All
Michael Alexanian joins Gladstone Institutes to discover new targets for treating and reversing heart failure
Institutional News News Release Profile Heart Failure Cardiovascular Disease Alexanian Lab
Gladstone researchers discover how to reverse cardiac scarring—and how this could treat heart failure
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab CRISPR/Gene Editing
A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs
A team at Gladstone Institutes screened the human genome for genes that play a role in making or consuming cellular energy
News Release Research (Publication) Parkinson’s Disease Heart Failure Neurological Disease Nakamura Lab Disease Models Genomics Metabolism
The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.
Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models
The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.
Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.
Gladstone Experts Research (Publication) Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Virology Bruneau Lab Conklin Lab Krogan Lab
The Stem Cell Podcast—Gladstone Senior Investigator Todd McDevitt describes his work using stem cells to understand how tissues grow and organize themselves, and how these efforts lay the groundwork for regenerative medicine therapies.
Gladstone Experts Heart Failure Cardiovascular Disease McDevitt Lab Organoids Stem Cells/iPSCs
Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.
Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab
Gladstone scientists gain important insights into the cellular reprogramming process
News Release Research (Publication) Heart Failure Cardiovascular Disease Pollard Lab Srivastava Lab Big Data Stem Cells/iPSCs
A new model system offers clues
News Release Research (Publication) Heart Failure Data Science and Biotechnology Conklin Lab
Gladstone scientists identify genes that enable adult cells to divide and multiply
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab
Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure
Haldar Lab Srivastava Lab Stem Cells/iPSCs Heart Failure
A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.
Heart Failure Congenital Heart Disease Bruneau Lab Haldar Lab Srivastava Lab Basic Science
Research on a gene mutation that causes holes in the hearts of infants revealed insights into how the heart develops and how it stays healthy.
Heart Failure Congenital Heart Disease Srivastava Lab
